| Literature DB >> 33920744 |
Fahd Alhaidari1, Abdullah Almuhaideb1, Shikah Alsunaidi2, Nehad Ibrahim2, Nida Aslam2, Irfan Ullah Khan2, Fatema Shaikh3, Mohammed Alshahrani4, Hajar Alharthi2, Yasmine Alsenbel2, Dima Alalharith2.
Abstract
With population growth and aging, the emergence of new diseases and immunodeficiency, the demand for emergency departments (EDs) increases, making overcrowding in these departments a global problem. Due to the disease severity and transmission rate of COVID-19, it is necessary to provide an accurate and automated triage system to classify and isolate the suspected cases. Different triage methods for COVID-19 patients have been proposed as disease symptoms vary by country. Still, several problems with triage systems remain unresolved, most notably overcrowding in EDs, lengthy waiting times and difficulty adjusting static triage systems when the nature and symptoms of a disease changes. In this paper, we conduct a comprehensive review of general ED triage systems as well as COVID-19 triage systems. We identified important parameters that we recommend considering when designing an e-Triage (electronic triage) system for EDs, namely waiting time, simplicity, reliability, validity, scalability, and adaptability. Moreover, the study proposes a scoring-based e-Triage system for COVID-19 along with several recommended solutions to enhance the overall outcome of e-Triage systems during the outbreak. The recommended solutions aim to reduce overcrowding and overheads in EDs by remotely assessing patients' conditions and identifying their severity levels.Entities:
Keywords: COVID-19; clinical diagnosis; diseases; emergency department; healthcare operations; priority; public healthcare; triage system
Mesh:
Year: 2021 PMID: 33920744 PMCID: PMC8072881 DOI: 10.3390/s21082845
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Patient classification approaches in EDs.
Common international ED triage systems.
| Triage System | Categories or Triage Levels ↓ | Waiting Time (In Minutes) | Published Year | Ref. | Remark |
|---|---|---|---|---|---|
| Australasian Triage Scale (ATS) | Resuscitation | 0 | 1993 | [ | - |
| Manchester UK (MTS) | Immediate | 0 | 1994 | [ | - |
| Canadian Triage and Acuity Scale (CTAS) | Resuscitation | 0 | 1999 | [ | It is updated every four years |
| South African Triage Scale (SATS) | Red | Immediate | 2004 | [ | - |
| France Clinical Emergency Department Classification (CCMU) | C1 | Not found | Not found | [ | It classifies patients based on the severity of their case which impacts the required treatment resources |
| France Multi-centric Emergency Department Study Group (GEMSA) | G1 | Not found | Not found | [ | It refers to the patient’s affiliation after treatment in the ED (inpatient, discharged) and the mode of admission (planned or unplanned) |
| Saudi Ministry of Health (MOH) | Emergent | Not found | 2003 | [ | There are several hospitals in Saudi Arabia adopting the CTAS system [ |
Figure 2EP classification of ED patients [8].
Figure 3Patients priority (the number next to each point represents the patient group) [45].
Figure 4Delay-based triage systems to prioritize patients [49].
Figure 5The procedure followed in the ED.
Comparison of general proposed ED triage systems.
| Approach # | Ref. | Aim | Improvement in | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Categories or Triage Levels | Guidance for Each Level | Required Information to Classify the Patients | Procedure/Criteria to do the Classifications | Performer (Users) | Priority-Based on | Digital | Remotely | |||
| 1 | [ | Enhancing the ED patient services and assist in resource allocating by forecasting daily attendance at an ED | 1. EP1 | EP1 stable and discharged | The case severity & number of resources | GEMSA categories and the CCMU probability mass function | - | - | ✓ | ✗ |
| 2 | [ | Telemonitoring system to classify and prioritize the patients | 1. Red (Risk) | 1. Direct the patient to the surgery room & its services | Sensors and text wireless body area network, 4 main ECG features related to various chronic heart diseases | Data fusion and fuzzy inference algorithms to estimate the priority | - | PC value and wait time | ✓ | ✓ |
| 3 | [ | Improving the triage process by developing dynamic grouping and prioritization (DGP) algorithm | 1. Very Severe | The patient goes to the waiting room, or the pediatric ER if the age under 18 years old | Gender, age, pain level, expected treatment time, and vital signs | Patients are categorized into eight types based on their priority, age, and group | Health care provider (The greeter’s desk collects the patient info and complaint, then pass it to a triage nurse) | FCFS (Unless the patient’s condition requires immediate care) | ✓ | ✗ |
| 4 | [ | Prioritize and schedule patient visits. Also, reduce the average waiting time | 1. Emergency | - | Patient health and vital status | Patient’s health and vital condition | Physician | The type and duration of service required | ✓ | ✗ |
| 5 | [ | Reducing the median waiting time outside the triage area to less than 30 min | 1. Fast Track | 1. Treatment area (TA) | - | - | Doctors & nurses | Risk level | ✗ | ✗ |
| 6 | [ | Reducing waiting time for high-priority patients | 1. Resuscitation | 1. Primary trauma care | levels of acuity | 1. primary trauma care | Chief physician | FCFS | - | ✗ |
| 7 | [ | Improving the system by managing waiting time | - | - | Vital signs | Level of risk of the patient’s condition | Triage nurse | Risk level | ✓ | ✗ |
| 8 | [ | Improving triage systems (CTAS) | - | Patients wait either in the waiting room or on a stretcher chair if the triage nurse deems it necessary | Determine the most appropriate CCD from a list of 474 possible conditions | - | Triage nurse, patient selection decisions are made by the Chief Nurse or ED official | FCFS | - | ✗ |
| 9 | [ | COVID--19 pandemic triage algorithm for EDs | 1. Red (Need Resuscitation) | - Admitted to intensive care (1, 2, and 3) | clinical features, and it is vital | Droplet: distance >6 feet (greens, some yellows) | - | Reduction in patient volumes | ✓ | ✓ |
Note: GEMSA: France Multi-centric Emergency Department Study Group, CCMU: France Clinical Emergency Department Classification, CTAS: Canadian Triage and Acuity Scale; FCFS: First Come First Service, DGP: dynamic grouping and prioritization, CCD: Chief Complaint Description; HR: Heart Rate; EDs: emergency departments.
Figure 6Triage Protocol by CDC [60].
Figure 7Virtual Triage Checklist at MOH, version v1.3 [64].
COVID-19 symptoms frequency.
| No. | Symptoms | Description | Criteria | Percentage [ | Percentage Others |
|---|---|---|---|---|---|
| 1 | Fatigue | Feeling of tiredness and an overall lack of energy | Feeling weak or sluggish. | 68% | 44–70% |
| 2 | Smell and taste disturbance | Troubles with the normal capabilities of smelling and tasting. | “Cannot smell or taste anything, or things smell or taste different to normal” [ | 64% | 58.6–75% |
| 3 | Dry cough | A cough that does not produce mucus. | Strong cough lasting more than an hour, or they have such incidents for three or more times in a day [ | 60% | 59–82% |
| 4 | Fever | High temperature | Temperature is 38 °C or over | 55% | 83–99% |
| 5 | Muscle pain | Soreness and achiness in the muscles | Mild to severe | 44% | 11–35% |
| 6 | Headache | A painful sensation in any part of the head | Ranging from sharp to dull | 42% | <10% |
| 7 | Shortness of breath | Breathing difficulties | Suffering from suffocation or being unable to take a breath | 41% | 31–44% |
| 8 | Sore throat | The raw, scratchy, burning feeling at the back of throat | Trouble breathing or swallowing | 31% | 14% |
| 9 | Anorexia and Digestive issues | Eating disorder | Lack of appetite, diarrhea, vomiting, or abdominal pain | NA | 40–84% |
Figure 8A flowchart of COVID-19 treatment in in Wuhan fever clinics [83].
Figure 9COVID-19 Symptoms.
Figure 10Triage system evaluation parameters.
Classification criteria of COVID-19 patients in approach 1.
| No. | Type | Criteria [ | Criteria [ | Guidance |
|---|---|---|---|---|
| 1 | Mild | Patient with unsophisticated upper respiratory tract viral infection and possibly having general symptoms such as fever, fatigue, and cough. |
Fever < 38 °C. No dyspnea, no gasping, and no chronic disease. | Isolation and monitoring in the hospital, in some cases home isolation is sufficient [ |
| 2 | Moderate |
Patients with moderate pneumonia of fever, cough, dyspnea, fast breathing. SpO2 is above or equal to 90% and patients do not require supplemental oxygen | Fever, respiratory symptoms, and imaging findings of pneumonia | Not found |
| 3 | Severe | Patients with the followings: Severe clinical signs of fever, cough, dyspnea, and fast breathing Any of:
Respiratory rate > 30 breaths/min. Severe respiratory suffering. OSpO2 < 90%. | Patients with any of the following: Respiratory distress but not failure issues SpO2 < 93% at rest PaO2/FiO2 ≤ 300 mmHg Rapid progression over 50% in 24–48 h on CT chest imaging | Not found |
| 4 | Critical | Acute respiratory distress syndrome (ARDS) Onset criteria Chest imaging criteria Origin of pulmonary infiltrates Oxygenation impairment Life-threatening organ dysfunction Signs of organ dysfunction Hypotension regardless of given resuscitation Demanding vasopressors to sustain MAP ≥ 65 mmHg Serum lactate level > 2 mmol/L | Patients with any of the following: Critical respiratory failure Shock Organ failure where ICU is a must | Not found |
Note: SpO2: blood oxygen saturation, ICU: intensive care unit, CT: Computed tomography; PaO2/FiO2: the ratio of arterial oxygen partial pressure to fractional inspired oxygen, mmol/L: millimoles per liter, mmHg: millimeters of mercury.
Classification criteria of COVID-19 patients in approach 2.
| No. | Type | Criteria [ | Guidance |
|---|---|---|---|
| 1 | Suspected Case | Having two or more of: Fever and/or respiratory symptoms. Pathological pneumonia Normal or low White Blood Cells (WBC) or decreased lymphocyte in early onset. Being in or traveling through a place where COVID-19 is present. Close contact with positive cases. Close contact with people from the area affected by COVID-19 or nearby regions. Cluster onset. | Not found |
| 2 | Confirmed Case | Any of the following etiological signs: Positive laboratory (rRT-PCR) or nucleic acid tests. High COVID-19 biological genetic sequence homology. | Not found |
Note: rRT-PCR: real-time reverse transcription polymerase chain reaction, WBC: white blood cells.
Classification criteria of COVID-19 patients in approach 3.
| No. | Type | Criteria [ | Guidance [ |
|---|---|---|---|
| 1 | ESI 1 |
Infected area that has been visited in the past 14 days, or infected person has been contacted, and have any symptoms of COVID-19 Not hemodynamically stable | Direct to Cardiopulmonary Resuscitation (CPR) room |
| 2 | ESI 2 |
Infected area that has been visited in the past 14 days, or infected person has been contacted, and have any symptoms of COVID-19 Hemodynamically stable Dyspnea SpO2 ≤ 93% | Supplemental oxygen treatment (Severe pneumonia) |
| 3 | ESI 3 |
Infected area that has been visited in the past 14 days, or infected person has been contacted, and have any symptoms of COVID-19 Hemodynamically stable Dyspnea SpO2 > 93% Underlying disease/immunodeficiency. With or without Fever ≥37.3 C | Direct to an isolated waiting room |
| 4 | ESI 4 |
Infected area that has been visited in the past 14 days, or infected person has been contacted, and have any symptoms of COVID-19 Hemodynamically stable Dyspnea SpO2 > 93% Not underlying disease/immunodeficiency. Fever < 37.3 C | Home care, directing the patient to other clinics, providing supportive/symptomatic treatment |
| 5 | ESI 5 | There has been no visit to an infected area in the last 14 days, no contact with an infected person, and no display of symptoms. | Direct to other health clinics or home care |
Note: ESI: Emergency Severity Index, CPR: Cardiopulmonary Resuscitation.
Classification criteria of COVID-19 patients in approach 4.
| No. | Type | Criteria [ | Guidance [ |
|---|---|---|---|
| 1 | High risk |
Score ≥ 10 Have an epidemiological history | Direct to the COVID-19 fever clinic |
| 2 | Medium risk |
Score ranging from 4 to 9 Have any of the clinical manifestations Have an epidemiological history | Direct to the COVID-19 fever clinic |
| 3 | Low risk |
Score from 1 to 3 Have any of the clinical manifestations Have epidemiological history | Direct to the COVID-19 fever clinic |
| 4 | No risk |
Score = 0 Does not have epidemiological history Have a fever | Direct to the general fever clinic. |
Figure 11Prevalence of reported COVID-19 symptoms.
Proposed studies on COVID-19 triage systems.
| Ref. | Type | Department | Objective | Classification Levels | Type of Criteria |
|---|---|---|---|---|---|
| [ | Plans and guidance | dermatology | protect against the spread of COVID-19 in the dermatology departments. | No levels | subjective |
| [ | remote triage system | cancer | advice patients with neck and head cancer. | Two levels | Risk rate |
| [ | guidance | electromyography | manage electromyography test requests during the COVID-19. | Three levels | subjective |
| [ | guidance | heart disease | triaging heart disease patients during the COVID-19 pandemic. | subjective | |
| [ | Resources assessment | ICU | Classifying patients with critical conditions at ICUs. | Two levels (low, high) | scores |
| [ | guidance | General ED | enhance the ED’s triage system during COVID-19. | Five levels as Emergency Severity Index | subjective |
| [ | questionnaire | Pediatric ED | early detection and controlling of children cases during COVID-19. | Three levels (High-risk, Medium-risk, Low-risk) | scores |
| [ | admission criteria | Pediatric ED | determine the mechanism for admission and entry of COVID-19 sick children into health care facilities | Two levels (suspected, unsuspected) | subjective |
| [ | Visual Triage Checklist | General ED | instructions and measures for Acute Respiratory Infection (COVID-19/MERS-CoV). | Two levels (respiratory pathway, None) | scores |
| [ | Guidance and admission rules | ICU | Optimize the usage of medical resources at ICU during COVID-19. | Two levels (admitted, None) | subjective |
Note: ED: Emergency department, ICU: intensive care unit, MERS-CoV: Middle East respiratory syndrome coronavirus.
Figure 12Classification criteria of COVID-19 for remote patients.
Recommended admission scored-based criteria for COVID-19.
| No. | Input Symptoms Type | Input Symptoms | Criteria | Score | Format |
|---|---|---|---|---|---|
| 1 | Exposure Risk | 2 text questions | Any of the followings Recently (14 days), contact with a COVID-19 confirmed case. Recently (14 days), lived in or worked in a facility known to be experiencing a COVID-19 outbreak. | 2 | Binary (Y/N) |
| 1 | Clinical Signs and Symptoms | Fever | Fever > 38 | 4 | Binary (Y/N) |
| 2 | Cough (new or worsening) | Coughing as described in [ | 4 | Binary (Y/N) | |
| 3 | Shortness of breath (new or worsening) | Suffocating, or unable to catch their breath | 4 | Binary (Y/N) | |
| 4 | Headache, sore throat, or rhinorrhea | Ranging from sharp to dull. | 1 | Binary (Y/N) | |
| 5 | Nausea, vomiting, and/or diarrhea | Lack of appetite, diarrhea, vomiting, or abdominal pain | 1 | Binary (Y/N) | |
| 6 | Chronic renal failure, Immunocompromised patient, CAD/heart failure | Existence of the disease | 1 | Binary (Y/N) |
Proposed severity level-based classification criteria for COVID-19 patients.
| No. | Type | Criteria [ | Possible Scores |
|---|---|---|---|
| 1 | Mild | 1. None of the below conditions: | 1–3 |
| 2 | Moderate | 1. One of the below conditions: | 4–7 |
| 3 | Severe | Scoring-based criteria: | 8–11 |
| 4 | Critical | Scoring-based criteria: | ≥12 |
KFUH dataset description.
| Type | Feature | Description and Format | Selected Status |
|---|---|---|---|
| General Info. | Case Id | Identification Number | |
| Age | Patient’s age as an integer | ||
| Clinical Signs and Symptoms | Fever | Yes/No recorded as Integer (1 or 2) | ✓ |
| Shortage of Breath | Yes/No recorded as Integer (1 or 2) | ✓ | |
| Cough | Yes/No recorded as Integer (1 or 2) | ✓ | |
| Chronic—Diabetes | Yes/No recorded as Integer (1 or 2) | × | |
| Chronic—Hypertension | Yes/No recorded as Integer (1 or 2) | ✓ | |
| Chronic—Cardiovascular | Yes/No recorded as Integer (1 or 2) | ✓ | |
| Chronic—Dyslipidemia | Yes/No recorded as Integer (1 or 2) | × | |
| Chronic—kidney disease | Yes/No recorded as Integer (1 or 2) | × |
Statistical results of the two groups constituted the used dataset.
| Target | Main Symptoms | Others | # Samples | |||
|---|---|---|---|---|---|---|
| Fever | Shortage of Breath | Cough | Hypertension | Cardiovascular | ||
| Group 1 | 22 | 30 | 21 | 17 | 8 | 43 |
| 51% | 70% | 49% | 40% | 19% | ||
| Group 2 | 118 | 87 | 117 | 38 | 10 | 134 |
| 88% | 65% | 87% | 28% | 7% | ||
Statistical results for Group 2.
| Information | Group 2 of the Dataset (134 Samples Where Target = 2) | |
|---|---|---|
| Severity Level | Severe Level | Critical Level |
| Criterion | Two of the main symptoms | All the three main symptoms |
| # samples | 80 | 54 |
| ration | 60% | 40% |
| Scoring Range | 8–11 | ≥12 |